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Background: Occiput posterior position is the most common malpresentation in labour, contributes to about 18%
of emergency caesarean sections and is associated with a high risk of assisted delivery. Caesarean section is now a
major contributing factor to maternal mortality and morbidity following childbirth in developed countries. Obstetric
intervention by forceps and ventouse delivery is associated with complications to the maternal genital tract and to
the neonate, respectively.
There is level 2 evidence that prophylactic manual rotation reduces the caesarean section rate and assisted vaginal
delivery. But there has been no adequately powered randomised controlled trial. This is a protocol for a double-blinded,
multicentre, randomised controlled clinical trial to define whether this intervention decreases the operative delivery
(caesarean section, forceps or vacuum delivery) rate.
Methods/Design: Eligible participants will be (greater than or equal to) 37 weeks’ with a singleton pregnancy and a
cephalic presentation in the occiput posterior position on transabdominal ultrasound early in the second stage of labour.
Based on a background risk of operative delivery of 68%, then for a reduction to 50%, an alpha value of 0.05 and a beta
value of 0.2, 254 participants will need to be enrolled.
This study has been approved by the Ethics Review Committee (RPAH Zone) of the Sydney Local Health District, Sydney,
Australia, and protocol number X110410.
Participants with written consent will be randomised to either prophylactic manual rotation or a sham procedure. The
primary outcome will be operative delivery (defined as vacuum, forceps and/or caesarean section deliveries). Secondary
outcomes will be caesarean section, significant maternal mortality/morbidity and significant perinatal mortality/morbidity.
Analysis will be by intention-to-treat. Primary and secondary outcomes will be compared using a chi-squared test. A
logistic regression for the primary outcome will be undertaken to account for potential confounders.
The results of the trial will be presented at one or more medical conferences. The trial will be submitted to peer review
journals for consideration for publication. There will be potential to incorporate the results into professional guidelines for
obstetricians and midwives.
Trial registration: The Australian New Zealand Clinical Trials Registry ACTRN12612001312831. Trial registered 12
December 2012.
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Persistent occiput posterior (OP) position is associated
with 18% of intrapartum caesarean sections and a high
risk of assisted vaginal delivery [1-3]. Caesarean section
is now a major contributing factor to maternal mortality
and morbidity following childbirth in developed coun-
tries [4,5]. Obstetric intervention by forceps and ven-
touse delivery is associated with complications to the
maternal genital tract and neonate, respectively [6-8].
Manual rotation from the OP to the occiput anterior
(OA) position is a safe, relatively simple and easy to per-
form procedure that could reduce the operative delivery
rate (defined as vacuum delivery, forceps delivery and/or
caesarean section) and therefore increase the chances of
a normal vaginal birth [9]. It is performed by only a mi-
nority of obstetricians and midwives in Australia and
New Zealand, yet is considered to be acceptable by the
vast majority [10,11]. However, obstetricians and mid-
wives would perform a manual rotation if there was evi-
dence that it reduced the risk of operative delivery to
50% or less [10,11] suggesting that demonstration of effi-
cacy will translate into clinical practice.
Preliminary studies of efficacy are promising, but there
has been no adequately powered randomized controlled
trial (RCT) [12,13]. It has been recommended that RCTs
be conducted to explore the efficacy of manual rotation
in the management of OP labours [14].
Epidemiology
The prevalence of the OP position is 15 to 32% at the on-
set of labour [15-18], 10 to 20% early in the second stage
of labour and 5 to 8% at delivery [2,17,19,20]. The opera-
tive delivery rate varies from 54% to 82% when the OP
position is present at delivery, compared with 6% to 22%
when the fetus is in the more common OA position
[3,16,19,20]. When the OP position is present at the be-
ginning of the second stage of labour, the operative deliv-
ery rate was about 70% in two higher risk cohorts [2,3].
Thus, of all women who plan to have a normal vaginal
birth, 10 to 20% will have a fetus in the OP position
early in the second stage of labour. These women will be
eligible to have a manual rotation to modify their back-
ground risk of up to 70% of obstetric intervention with
forceps, vacuum or caesarean section.
Complications of the occiput posterior position
The OP position is associated with more frequent induc-
tion and augmentation of labour and prolonged first and
second stage of [3,17,18,21], chorioamnionitis, post-
partum haemorrhage, third and fourth degree perineal
tears, wound infection and endometritis [22,23]. Associ-
ated adverse neonatal outcomes include birth trauma,
low 5-minute Apgar score, and admission to the neo-
natal intensive care unit [24].The intervention in current practice
Manual rotation is a well-accepted component of obstet-
ric practice, particularly in the context of rotating the
fetus to the OA position immediately prior to the appli-
cation of non-rotational forceps such as Neville-Barnes
[25]. However, it is also used commonly in a prophylac-
tic setting (without assisted delivery) to reduce the com-
plications associated with OP delivery [12,13]. In a
survey of obstetricians in Australia and New Zealand,
70% believed it was acceptable in a prophylactic setting;
but only 38% had performed a manual rotation in the
last year, and most of these had only performed one or
two [10]. Both obstetricians and midwives reported they
would perform a manual rotation if there was evidence
that it would reduce the chances of operative delivery
from 68% to 50% or less [10,11]. Thus demonstration of
efficacy would provide substantial scope for the inter-
vention to be introduced into widespread practice.
The efficacy of the intervention
Preliminary cohort studies report that manual rotation is
associated with a reduction in caesarean section and ad-
verse maternal outcomes:
1. In a retrospective cohort study, Schaffer et al. (2006)
(n = 731) reported that the caesarean section rate
was lower in women who had a successful manual
rotation compared to when the fetus was unable to
be rotated (2% versus 34%) [26]. However, there was
no control group of women for whom a manual
rotation was not performed and it is not possible to
know if this was due to the procedure itself or to
underlying confounders such as a smaller fetus.
2. In a prospective cohort study with historical
controls (n = 61), the local labour ward policy was
changed from not performing prophylactic manual
rotation to routinely performing the procedure for
OP position about ‘half way’ into the second stage of
labour [12]. The operative delivery rate for fetuses in
the OP position fell from 73% prior to the change in
policy to 23% after the policy was implemented, but
this study design is subject to a significant risk of
bias.
3. Schaffer et al. (2011) re-reported their 2006 data
with a control group identified retrospectively from
a database and found a 9% risk of caesarean section
when manual rotation was performed compared
with a 41% risk when it was not [13]. However, the
authors had information on the fetal position at the
time of birth but not earlier in the second stage of
labour when the procedure was performed. Thus OP
fetuses that were destined to rotate naturally to the
OA position would have been included in the inter-
vention group, but not the control group, which
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section rate in the control group and of the efficacy
of manual rotation.
Thus preliminary studies suggest that manual rotation
reduces the risk of operative delivery but are susceptible
to significant bias. An RCT would best provide unbiased
answers regarding the effects of manual rotation of the
fetal occiput on maternal and perinatal outcomes.
The safety of the intervention
Manual rotation has long been considered to be safe [9].
One retrospective cohort study reported lower rates of
complications when it was performed for OP position
compared to when it was not (Table 1) [13]:
Thus, third and fourth degree tears, chorioamnionitis,
post-partum haemorrhage, endometritis and 5-minute
Apgars less than 7 all improved when prophylactic manual
rotation was performed. but cervical laceration was
increased.
In the POP-OUT trial manual rotation will be per-
formed at full dilatation, which theoretically will minimize
the risk of cervical laceration.
There is also a single case report of an umbilical cord
prolapse associated with a manual rotation [27]. In this re-
port, an emergency caesarean section was performed and
the baby was born alive and presumably well. Other risk
factors such as amniotomy, application of a fetal scalp
electrode and external cephalic version were more fre-
quently associated with umbilical cord prolapse [27].
The timing of the intervention
Manual rotation from the OP position may be performed
at full cervical dilatation or late in the first stage of labour.
In a French case control study (n = 147) in a labour ward
where prophylactic manual rotation was performedTable 1 Complications of manual rotation versus






Postpartum haemorrhage 22.3% 33.1% <0.001
3rd and 4th degree tears 15.7% 20.1% 0.017
Cervical laceration 2.2% 1.0% 0.024
Chorioamnionitis 8.6% 14.4% <0.001
Endometritis 3.6% 7.2% <0.001
5-min Apgars <7 1.8% 3.7% 0.011
Umbilical cord arterial pH
<7 0.6% 1.4% 0.15
Base excess < −12 3.5% 3.2% 0.73
Shoulder dystocia 2.1% 1.1% 0.064
Birth trauma 1.09% 1.23% 0.77routinely, two risk factors for inability to rotate the fetus
were identified: [1] attempted rotation before full dilatation
and [2] failure to progress in labour [28]. Thus. we consider
that it would be reasonable to attempt prophylactic manual
rotation after full dilatation is achieved, but relatively early
in the second stage of labour, before the fetal head becomes
impacted in the maternal pelvis.
Rationale for operative delivery as the primary outcome
Operative delivery was selected as the primary outcome
for the POP-OUT Trial because it is clearly associated
with important short- and long-term outcomes for the
woman and her baby [6-8,29-32]. Other important obstet-
ric parameters will be measured, but reported as second-
ary outcomes. Reducing the rate of operative delivery for
OP position is perceived to be very important by obstetri-
cians and midwives [10,11]. In high income countries,
emergency caesarean section is associated with significant
maternal morbidity and a fivefold increase in maternal
mortality [33].
Explanation for choice of comparator
A sham procedure was chosen as a comparator to
minimize the risk of performance bias. There would be
substantial scope for management to differ according to
treatment allocation if it was known. For example, a
women could be encouraged to push more strongly if her




The aim of the study is to determine the efficacy of
elective manual rotation in the management of OP pos-
ition in the second stage of labour.
Hypothesis
Among women who are at least 37 weeks gestation and
whose baby is in the OP position early in the second
stage of labour, manual rotation compared with a ‘sham’
rotation will result in a reduction in operative delivery.
Primary objectives
The primary objectives are to determine the differences
between intervention and control groups in the opera-
tive delivery rate (defined as vacuum, forceps and/or
caesarean section deliveries).
Secondary objectives
The secondary objectives are to determine the differ-
ences between intervention and control groups in cae-
sarean section, in the combined measure of serious
maternal morbidity and mortality within six weeks of
birth, and in the combined measure of serious perinatal/
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birth.
Trial design
The POP-OUT trial is designed as a superiority, double-
blinded, multicentre, randomised controlled clinical trial
with two parallel groups and a primary endpoint of opera-
tive delivery. Randomization will be performed as block
randomization with a 1:1 allocation.
Study settings
Hospitals in Australia that have 2,000 or more deliveries
per year include the following:
1. Canterbury Hospital, NSW
2. The John Hunter Hospital, NSW
3. The Nepean Hospital, NSW
4. The Royal Hospital for women, Randwick, NSW
5. The Royal Prince Alfred Hospital, NSW
6. The Women and Children’s Hospital, SA
We do not intend to recruit in any other centres. A list




Inclusion criteria include the following:
1. age ≥ 18 years
2. singleton pregnancy
3. ≥37 weeks of gestation
4. planned vaginal birth
5. cephalic presentation
6. full cervical dilatation
7. occiput posterior position confirmed by ultrasound
where the occiput is <45° from the midline
Exclusion criteria
Most exclusion criteria were selected on the basis of pre-
disposition to requiring an operative delivery and are as
follow:
1. clinical suspicion of cephalopelvic disproportion
2. previous caesarean section
3. brow or face presentation
4. ‘Pathologic’ CTG according to RCOG classification
plus either baseline >160 beats per minute or
reduced variability
5. fetal scalp pH <7.25 or lactate >4
6. known or suspected chorioamnionitis
7. intrapartum haemorrhage >50 mL
8. temperature ≥38.0°C in labour
9. pre-existing maternal diabetes10. suspected fetal bleeding disorder (theoretical risks
associated with procedures involving manipulation
of fetal position)
11. known major anatomical fetal abnormality (could
influence safety or efficacy of manual rotation).
Eligibility criteria for study centres
Ability to provide a 24-hour on-call service with experi-
enced operators to perform the intervention.
Individuals who will perform the intervention
Only obstetricians or midwives who are experienced in
performing a manual rotation and have performed at least
20 procedures will participate in the study. All operators




Manual rotation is performed at full dilatation if the fetal
position is OP. The technique employed will be at the
discretion of the operator performing the procedure.
With the membranes ruptured, a vaginal examination is
performed and the woman is asked to bear down. Con-
stant pressure is exerted with the index finger against the
lambdoid suture to rotate fetal head. This may take 2 to 3
contractions and the position is commonly held for two
contractions while the woman bears down to reduce the
risk of reverting back to the OP position.
Alternatively, the examiner places two fingers behind
the fetal ear or the entire hand behind the occiput and
applies constant flexion and rotation to the fetal head.
For purposes of the POP-OUT Trial, the procedure
will be described as a ‘manual rotation (digital)’ if only
the fingers are used and as a ‘manual rotation (whole
hand)’ if the whole hand is used.
Comparator: sham procedure
Comparator description
Women randomized to the ‘sham rotation’ will have the
same apparent vaginal examination as the intervention
but no rotational force will be applied. The woman is
asked to bear down. The accoucheur places fingers in
the vagina over 5 contractions as if s/he were performing
a manual rotation.
The timing of the intervention
The intervention will begin once full dilatation has been
diagnosed and the woman has the first urge to push or
after one hour, whichever occurs first.
Criteria for discontinuing or modifying the intervention
The intervention or sham will be discontinued if there is
a clinical necessity or at the request of the participant.
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necessitating emergent delivery or if the participant is in
significant discomfort.
Each operator will complete a data collection form at
the time of the procedure or sham, which will describe
in detail what was done. Adherence with treatment allo-
cation will be monitored by comparing these datasheets
with the computer randomisation records.
All interventions and usual care provided by doctors
and midwives looking after the participant will be
allowed. However, if the doctor is intending to perform
an operative delivery or a manual rotation, the woman
will not be randomised. Data will be collected about use




The primary outcome will be operative delivery (vac-
uum, forceps and/or caesarean section).
Secondary outcomes
Secondary outcomes will include the following:
1. Caesarean section (reported as proportion of
participants who had a caesarean section) and
2. Serious maternal morbidity or mortality (combined
outcome), which includes the following: post-partum
haemorrhage requiring blood transfusion, third or
fourth degree perineal trauma; dilatation and curet-
tage for bleeding or retained placental tissue; cervical
laceration; vertical uterine incision; vulvar or peri-
neal haematoma; pneumonia; venous thrombo-
embolism requiring anticoagulation; wound infection
requiring hospital stay more than 7 days; readmis-
sion to hospital for obstetric-related causes; wound
dehiscence; maternal fever of at least 38.5°C on two
occasions at least 24 hours apart not including the
first 24 hours; bladder, ureter or bowel injury requir-
ing repair; genital-tract fistula; bowel obstruction; or
admission to intensive care unit. This will be re-
ported as a proportion of participants with serious
morbidity or mortality.
3. Serious perinatal/neonatal morbidity or mortality
within 6 weeks of birth (combined outcome), which
will include the following: shoulder dystocia requiring
manouvres other than McRoberts/suprapubic
pressure or resulting in neonatal injury, 5-minute
Apgars < 4; arterial cord pH <7.0 or lactate >10 or
base excess < −15; seizures < 24 hours of age, intub-
ation/ventilation >24 hours, tube feeding >4 days, ad-
mission to neonatal intensive care >4 days, neonatal
jaundice requiring phototherapy, neonatal fracture, in-
traventricular/intracranial haemorrhage, subgalealhaemorrhage, neonatal blood transfusion, hypoxic is-
chaemic encephalopathy, or neuropraxia. This will be
reported as a proportion of participants with serious
morbidity or mortality.
Other outcomes
Other outcomes will be assessed during delivery admis-
sion and at t 6-weeks, 6-months, and 1-year postpartum.
The following outcomes will be assessed during deliv-
ery admission:
1. length of second stage (median)
2. time from intervention or sham until delivery
(median)
3. estimated blood loss at delivery (median: visual
estimation by midwife or doctor)
4. any perineal/vaginal trauma requiring suturing
(proportion)
5. length of hospital stay (median)
The following outcomes will be assessed at 6 weeks:
1. still breast feeding (proportion)
2. satisfaction with birth (VAS scale) (median)
3. saw a health professional for depression since
delivery (proportion)
4. health-related quality of life (SF-12) (median)
The following outcomes will be assessed at 6 months:
1. still breast feeding (proportion)
2. saw a health professional for depression since
delivery (proportion)
3. health-related quality of life (SF-12) (median)
The following outcomes will be assessed at one year:
1. still breast feeding (proportion)
2. saw a health professional for depression since
delivery (proportion)
3. health-related quality of life (SF-12) (median)
4. pelvic floor function (bowel, urinary, prolapse, and
sexual function domains - using the Australian pel-
vic floor function questionnaire [34] (medians)
Sample size
The sample size (254) was calculated on the basis of the
primary outcome. The power calculation was based on
our prospective cohort study of 160 women that was
completed in May 2009 [3] and showed an operative de-
livery rate of 68% in the OP group, and from our survey
of obstetricians conducted in 2010, who indicated they
would perform a manual rotation for OP position if it
reduced the rate of operative delivery from 68% to 50%
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ery from 68% in the control group to 50% in the inter-
vention group, a sample size of 127 women in each
group (total = 254) will be required to have 80% power
of finding a result. Alpha = 0.05 (2-tailed), Beta = 0.20
(Epi-Info version 3.3.2).
Randomization/allocation concealment
Randomization will be stratified by parity, hospital site
and epidural due to the potentially strong association
between operative delivery (the primary outcome) and
each of these factors. Randomization will be centrally
controlled using computerized sequence generation,
which can be accessed 24 hours per day using a toll-free
telephone line.
In order to reduce the risk of randomising an ineligible
participant, randomisation will occur immediately before
the intervention or sham procedure is to be performed.
An example of a participant becoming ineligible would
be if the fetus rotated from the occiput posterior to occi-
put transverse position. Each investigator will complete
a data collection form at the time the manual rotation
or sham procedure is performed outlining the treatment
allocation, clinical findings, and whether or not the fetus
was successfully rotated.
Blinding
The following groups will be masked:
1. The participants
2. The clinicians caring for the participant (including
doctors and midwives)
3. The data collectors
4. The statisticians who will perform the analysis
Unblinding
Unblinding will occur if the clinician requests it on the
basis of clinical need or if the participant insists.
Data collection, management and analysis
Study conduct
Consent will occur at three possible time points
Figure 1:
a) Antenatally
b) In the latent phase of labour
c) In the active phase of the first stage of labour, with
an effective epidural anaesthesia
An ultrasound will be performed at full dilatation by
the clinician caring for the woman and the findings will
be recorded on a data sheet immediately afterwards.
An hour after full dilatation or at the first urge to
push, a study investigator (with no clinical responsibilityfor the woman in the trial) will confirm the OP position
by a second (pre-procedure) bedside ultrasound. If the
fetal position is still OP and the woman still wishes to
participate, then the study investigator will randomise
the woman to either manual or sham rotation. The
treatment allocation will be recorded on a randomisation
sheet that the investigator will keep on their person and
not show to any of the participant’s carers.
After the manual rotation or sham has been performed
the ultrasound will be repeated, ensuring that the
woman and her carers do not see the screen. The inves-
tigator will leave and the woman will have her usual care
from this point onwards. The investigator will record
the findings of the vaginal examination he/she per-
formed before the procedure, details of the procedure
and post-procedure ultrasound findings on the same
data sheet as the pre-procedure ultrasound. The study
investigator will also keep this data sheet on their person
and not show it to any of the participants’ carers.
Consent
Participants will be provided with written information
via information pamphlets, posters and the trial website.
Informed consent will be obtained by research midwives
or midwives/medical staff involved in potential partici-
pants’ care (Figure 1, Table 2). A detailed information
sheet will be provided to all participants. Participants
will be informed of the potential risks of manual rota-
tion, including umbilical cord prolapse, given the oppor-
tunity to ask questions and informed that they have the
right to change their mind at any time.
Primary outcome
Mode of delivery will be ascertained from the medical
records.
Other outcomes
Labour and delivery outcomes, perineal trauma, blood
loss, duration of hospitalisation, short-term neonatal out-
comes, and admission to the neonatal intensive care unit,
maternal or neonatal readmission to the same institution,
and other components of the combined secondary out-
comes will be ascertained by a study investigator not in-
volved in clinical care, using the medical records recorded
contemporaneously by the clinician and by contacting the
participants’ clinician for further information if required.
Maternal depression, health related quality of life (SF-12),
birth satisfaction (VAS), maternal or neonatal readmission
to another institution, ongoing breast feeding, pelvic floor
symptoms and components of the combined secondary
outcomes will be collected by structured maternal ques-
tionnaires at 6 weeks, 6 months and 12 months post-
delivery as outlined in section 15. Questionnaires will be
completed by mail-out, online via the trial website and by
Figure 1 An overview of the conduct of the POP-OUT Trial.
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(Figure 1, Table 2). Data collectors will be unaware of the
treatment allocation at all times.
As the primary outcome is mode of delivery and ran-
domisation occurs during the second stage of labour, we
expect 100% ascertainment for the primary outcome.
Study investigators will perform site visits about four
times per year to promote recruitment, provide educa-
tion for clinical staff and site investigators and to audit
centre medical records to verify the accuracy of the data
collected by the sites.Each participants will receive a phone call at each time
point by research staff not involved in her care to ask
her preference for follow-up. Unless she declines further
participation, each participant will receive a reminder
phone call and will be offered completion of the ques-
tionnaire by telephone if they feel they cannot complete
it by mail or online.
Data management
Data collected will be entered into a registered electronic
database by research staff blinded to treatment allocation










1-3 days 6 wks 6 mths 12 mths
1st Eligibility screen X
2nd eligibility screen X








Maternal complications X X
Hospital stay X
Readmission X
Neonatal outcomes X X
NICU admission(s) X X
Satisfaction with birth X
Breast feeding X X X
Health related quality of life X X X
Pelvic floor X X X
Depression X X X
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pants. Hardcopies of participants’ data will be stored in a
locked office. The electronic database will include the
study identification number but no directly identifying
data such as medical record number, date of birth or per-
sonal address. The de-identified database will be backed
up on a server at Royal Prince Alfred Hospital. Data link-
ing identifying details to the study number will be kept at
a separate location in a locked filing cabinet. At the end of
the study, data will be kept in a locked filing cabinet, and
de-identified electronic data will be kept on a portable
medium such as a USB drive in a separate secure location
at Royal Prince Alfred Hospital.
All electronic data will be checked for accuracy by a
second member of the research team and any apparent
data entry errors will be discussed by the primary inves-
tigators and investigated/corrected as required.
Analysis
Analysis will be by intention-to-treat (according to treat-
ment allocation), including withdrawals and losses to
follow-up. Losses to follow-up for the primary outcome
are not expected because randomisation will occur at
full dilatation and the primary outcome is the mode of
delivery.The results will be reported according to CONSORT
guidelines.
Demographics and other potential confounders will be
compared by treatment allocation in a univariate ana-
lysis. Categorical outcome measures will be compared by
proportions (chi-squared test), means for normally dis-
tributed data (t-test), or rank order for non-normally
distributed data (Mann–Whitney-U test).
A logistic regression analysis of treatment allocation
and other variables on the primary outcome measure,
operative delivery, will be performed. The following vari-
ables will be considered for the logistic regression model:
maternal body mass index, maternal age, maternal
height, maternal ethnicity, gestation, induction of labour,
gestational diabetes, neonatal gender, and RCOG CTG
classification in the second stage of labour. Parity, study
site and the presence of epidural for intrapartum anal-
gesia at the time of randomisation will not be included
because randomisation is stratified for these variables.
Only variables where P <0.25 in the univariate regression
will be included in the multivariate model. Continuous
variables that do not show a linear association with the
logit function will be divided into quartiles and treated
as categorical. Interaction terms will be considered for
treatment allocation versus each of the other variables
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variables. P <0.01 will be considered evidence of inter-
action. Terms will be excluded from the model in a step-
wise backward manner until all remaining terms are
both statistically significant (P <0.05) and clinically signifi-
cant (that is, removal of the term results in a clinically sig-
nificant change in the estimate of the odds ratio of
treatment allocation for the primary outcome). The ana-
lysis will be performed using SAS 9.2 (or a more recent
version of SAS).
Subgroup analyses will be performed according to the
technique of manual rotation employed (manual/whole
hand versus digital/fingers) and according to operator
ability (data will be divided into two approximately equal
groups according to the success rate of the operator who
performed the manual rotation).
Data safety monitoring committee
Draft terms of reference for a data and safety monitoring
committee provide for potential cessation of the trial if
significant safety concerns are raised. The data and
safety monitoring committee will consist of three people
who are not involved in the study and do not have a
working relationship with the primary investigators. Ad-
verse events will be reported to the committee.
Interim analysis and stopping rules
There will be no interim analysis. The Data Safety Moni-
toring Committee may advise that the trial be stopped if
significant concerns about the safety of manual rotation
are found.
Harm
Any serious complications will be referred to the Data
Monitoring Committee.
Auditing
There will be no external auditing of the trial.
Research ethics approval
This study has been approved by the Ethics Review
Committee (RPAH Zone) of the Sydney Local Health
District, Sydney, Australia, Protocol number X110410.
Discussion
This trial addresses an important clinical question con-
cerning a commonly used procedure that has the poten-
tial to reduce operative delivery and its associated
complications. Due to the nature of the intervention, a
number of issues are worthy of discussion.
First, empirical evidence suggests that blinding reduces
bias in randomised controlled trials. However, blinding
may be difficult in the case of procedural interventions.
In this trial, we intend to assess the efficacy of blindingby asking the woman’s carer to guess the treatment allo-
cation after manual rotation or sham rotation has oc-
curred. The purpose of this is to allow the reader to
assess the risk of bias associated with knowledge of
treatment allocation.
Second, the efficacy of procedural interventions may
depend on the experience and training of individual op-
erators. The ‘success’ of manual rotation of individual
operators will be assessed by recording the ultrasound
determined fetal position after the manual rotation or
sham procedure has been performed. We will report on
any major differences between the success rates of indi-
vidual practitioners.
Third, due to the ethics of consent in labour, consent
will be obtained when it is unknown if the fetus will be
in the occiput posterior position in the second stage of
labour, which is an eligibility criterion. Thus, it is likely
that only a minority of consented participants will be
randomised, which will result in a large workload per
randomisation (the pilot study was used as a reference).
Finally, women who progress rapidly in labour may
give birth before they can be randomised and women
with regional analgesia will have more opportunity to be
consented. This could result in the study population
having a higher background risk of the primary outcome
than non-consented women who meet our eligibility cri-
teria, which could impact the generalisability of our
findings.
Protocol amendments
If modification to the study protocol is considered ne-
cessary, then permission will be sought from the ethics
committee and the changes will be described in the final
report.
Confidentiality
All the information collected from the study will be
treated confidentially, and only the researchers will have
access to it. Hard copies of data collection forms will be
stored in a locked office. The electronic database will be
de-identified and stored at a different location to codes
linking identifying data to study identification numbers.
The electronic database will be on Microsoft Access,




The committee consists of Hala Phipps, Jon Hyett and
Bradley de Vries, who are responsible for the following:
1. Study planning
2. Organisation of Steering Committee meetings
3. Randomisation
Phipps et al. Trials  (2015) 16:96 Page 10 of 114. Reporting of any serious adverse events to the Data
Monitoring Committee
5. Budget administration and organising contracts with
individual centres
6. Providing advice for site investigators
7. Auditing and visiting sites
8. Data verification
9. Following up of study participants
Site investigators
In each participating centre, a lead investigator (obstetri-
cian) will be responsible for identification, recruitment data
collection and completion of relevant trial forms, along
with adherence with study protocol. Each lead investigator
will be a steering committee member.
Steering committee
The Steering Committee will be chaired by Brad de
Vries, and all lead investigators will be steering commit-
tee members and are responsible for the following:
1. Recruitment of pregnant women on the study and
liaising with principal investigators HP, JH and BD.
2. Reviewing progress of study and facilitating the
smooth running of the trial.
3. Reporting the results of the trial.
Data manager
The data manager will be responsible for maintenance
of the trial IT system, data entry and data verification.
Trial status
Start date: 16 April 2012.
Number currently recruited: 160.
Abbreviations
ARM: artificial rupture of membranes; CS: caesarean section; NSW: New South
Wales; NICU: neonatal intensive care unit; OA: occiput anterior; OP: occiput
posterior; OT: occiput transverse; PPH: postpartum haemorrhage;
RCT: randomised controlled trial.
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